Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Poly(ADP-ribose) polymerase (PARP) and chronic heart failure

P. Pacher, C. Szabo

Med Sci Monit 2003; 9(1): 52-0 :: ID: 15115

Abstract

Overactivation of the nuclear enzyme PARP importantly contributes to the development of cell dysfunction and tissue injury in various pathophysiological conditions associated with oxidative stress, including myocardial reperfusion injury, heart transplantation, stroke, shock and diabetes. We investigated the effects of a novel ultrapotent poly(ADP-ribose) polymerase (PARP) inhibitors PJ34 and INO1001, on cardiac and endothelial dysfunction in rat models of chronic heart failure (CHF) induced by either chronic ligation of the left anterior descending coronary artery or by the administration of the cytotoxic drug doxorubicin (DOX). In the CHF model, left ventricular function and ex vivo vascular contractility and relaxation were measured 10 or 8 weeks after the surgery. Nitrotyrosine (NT) formation and PARP activation were detected by immunohistochemistry. CHF and DOX induced increased NT formation and PARP activation in the myocardium and intramural vasculature, depressed left ventricular performance and impaired vascular relaxation of aortic rings. PJ34 and INO1001 significantly improved both cardiac dysfunction and vascular relaxation and delayed CHF- and DOX associated mortality. Thus, PARP activation plays a key role in the pathogenesis of various forms of chronic heart failure. References: 1.Virág L, Szabó C: The therapeutic potential of PARP inhibition. Pharmacological Reviews, 2002; 54: 375-429 2.Soriano FG, Virág L, Jagtap P et al: Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nature Medicine, 2001; 7: 108-113 3.Pacher P, Liaudet L, Soriano FG et al: The role of poly(ADP-ribose) polymerase in the development of chronic heart failure. J Am Coll Cardiol, 2002; 40: 1006-1016

Keywords: myocardial dysfunction, peroxynitrite, Ischemia

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis Patients

Med Sci Monit In Press; DOI: 10.12659/MSM.947630  

Clinical Research  

Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in T...

Med Sci Monit In Press; DOI: 10.12659/MSM.947450  

0:00

Clinical Research  

Impact of Voltage Level on Hospitalization and Mortality in Electrical Injury Cases: A Retrospective Analys...

Med Sci Monit In Press; DOI: 10.12659/MSM.947675  

Clinical Research  

Comparative Study of Plantar Load and Foot Posture Characteristics in Male Elite Squash Players and Non-Ath...

Med Sci Monit In Press; DOI: 10.12659/MSM.947828  

Most Viewed Current Articles

17 Jan 2024 : Review article   8,044,083

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,972

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   30,118

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   24,024

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750